ロード中...
Letrozole in the neoadjuvant setting: the P024 trial
Neoadjuvant chemotherapy trials have consistently reported lower response rates in hormone receptor-positive (HR+) breast cancer when compared with HR− cases. Preoperative endocrine therapy has therefore become a logical alternative and has gained considerable momentum from the finding that aromatas...
保存先:
| 主要な著者: | , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Springer US
2007
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2001223/ https://ncbi.nlm.nih.gov/pubmed/17912634 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-007-9701-x |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|